How to Help Your Patients Find Zyflo in Stock: A Provider's Guide

For allergists, pulmonologists, and any clinician managing complex asthma, access to zileuton (Zyflo) can be a persistent thorn. The drug is not in formal shortage, but patients — especially those with aspirin-exacerbated respiratory disease (AERD) — frequently report inability to fill their prescriptions. This guide is a practical, actionable resource for you and your clinical team to address that access gap head-on.

Why Zileuton Access Is a Structural Problem, Not a Supply Problem

Zileuton's access challenges stem from three root causes, none of which are traditional supply chain disruptions:

Pharmacy economics: At $2,800-$4,000 retail per 30-day supply with low prescription volume, most community pharmacies don't stock it. The inventory risk-to-reward ratio doesn't work in Zyflo's favor.

Insurance friction: Prior authorization, step therapy requirements, and high Tier 3-4 copays create delays that interrupt therapy even when the drug is technically available.

Prescriber-to-pharmacy communication gaps: Patients often go to their default pharmacy without knowing it doesn't stock Zyflo, rather than being directed to a pharmacy where it's available.

Understanding these root causes allows you to address each one proactively before your patient encounters a wall.

Strategy 1: Identify Your Local 'Zileuton-Friendly' Pharmacies

One of the highest-leverage interventions you can make is to identify 1-3 pharmacies in your service area that reliably stock zileuton and always direct new Zyflo prescriptions there. Here's how to build that list:

Ask your medical assistant or front-desk staff to call 5-6 local pharmacies (mix of chains and independents) to confirm they stock Zyflo CR 600 mg. Update this list quarterly.

Give this list to every patient you start on zileuton at their initiation visit.

Consider establishing a preferred-pharmacy relationship — some pharmacies will prioritize your patients if you consistently route prescriptions to them.

Hospital outpatient and university-affiliated pharmacies often stock specialty medications more reliably than community chains.

Strategy 2: Point Patients to medfinder

For patients who have trouble finding Zyflo, medfinder provides a practical solution. medfinder calls pharmacies near the patient to check which ones have Zyflo in stock and can fill the prescription right now. The patient enters their medication, dose, and ZIP code — medfinder does the calling and texts back the results. This removes the burden from both the patient and your clinical team.

Consider adding medfinder.com to your printed medication start-up instructions for all zileuton patients, particularly those in areas where you've seen access problems before.

Strategy 3: Streamline Prior Authorization at the Point of Prescribing

Waiting until your patient calls from the pharmacy with a PA denial is too late. Build zileuton prior authorization into your workflow at the time of prescribing:

At the visit when you prescribe zileuton, immediately submit a PA request to the insurer — don't wait for the pharmacy to trigger it.

Document in your note: diagnosis (AERD, aspirin-exacerbated asthma, or chronic persistent asthma), prior treatments tried and failed (montelukast, ICS), current LFTs, and the clinical rationale for why zileuton specifically is indicated.

Have a templated prior authorization letter ready for your common payers. Reference the mechanistic distinction between 5-LOX inhibition and LTRA receptor blockade for AERD cases.

If the initial PA is denied, prepare to appeal promptly. Most plans allow peer-to-peer review, which is often the fastest path to reversal.

Strategy 4: Inform Patients About Discount Options That Bypass Insurance

When insurance delays or high copays create access barriers, discount cards can be a practical bridge. GoodRx coupons reduce Zyflo CR (120 tablets, 30-day supply) to approximately $260-$315. SingleCare offers similar savings.

These programs work independently of insurance and don't require prior authorization. For patients in PA limbo or those with high-deductible plans, paying $260-$315 out-of-pocket with a coupon may be faster and less stressful than navigating insurance for weeks.

The PAN Foundation may also provide financial assistance for qualifying patients. Refer patients with significant financial hardship to explore patient assistance programs.

Strategy 5: Use 90-Day Supply Prescriptions for Established Patients

For stable patients who are adherent and tolerating zileuton well, writing for 90-day supplies through a mail-order or specialty pharmacy dramatically reduces the frequency of access-related crises. Many insurers require mail-order for maintenance medications after the first 2-3 fills — which also tends to result in lower copays for the patient.

Strategy 6: Counsel Patients to Refill Early — Never Run Out

Build refill counseling into every zileuton follow-up visit. The simple message: 'Start looking for your refill when you have 10 days of medication left, not when you run out.' For a drug that may need to be ordered, this buffer is essential. If your EHR system allows, set up a refill reminder trigger for zileuton patients at 20 days remaining.

When Access Truly Fails: Clinical Bridging Options

If a patient runs out of zileuton and cannot obtain a refill within 24-48 hours, brief clinical bridging options include:

Temporarily increasing ICS dose if the patient is already on an ICS and can tolerate the increase

Adding or increasing the dose of a rescue bronchodilator (SABA) for symptom control

In AERD patients, bridging with a short oral corticosteroid course while working to locate zileuton — though this is a last resort given the steroid exposure

See also: Zyflo Shortage: What Providers and Prescribers Need to Know in 2026